More than 3 character to search
Nov.2013 - PRESENT - European Institute of Oncology (IEO), Milan Italy – Director of Thoracic Oncology Division
2000 To October 2013 - San Camillo & Forlanini Hospitals, Rome Italy - High Specialization Hospital – Lung Disease- Director 1st Oncological Pulmonary Unit
From 2007 to 2010 - Private University of Rome “Campus Biomedico”- Postgraduate School- Professor in Oncology
From January 30th 1998 to August 2000 - Carlo Forlanini Hospital, Rome IT - Executive Manager
1996 - 1998 - Biomedical Sciences and Oncology Superior School – Rome and Cagliari - Teacher
April 06th 1995 To January 30th 1998 - Carlo Forlanini Hospital, Rome IT
1993 - 1996 - Marseille University – FR - Clinical Studies Institute and Pneumopthisiological Researches Professor
February 16th 1991 - 1995: Carlo Forlanini Hospital, Rome IT - Special Assistant of Pneumology, competitive examination, in USL RM/10
1990 - Ministry of Health, Forensic Medicine Office - Consultant for Pneumology in medical colleges - Forensic Medicine advisor
1987 to 1991 - Carlo Forlanini Hospital, Rome, Pneumological Assistant non in role
1987 - 1999 Teacher at S.M.O.R.R.L. - Rome & Lazio Hospital Medical School
1985 - 1989: Teacher at the Professional Nurses School “Carlo Forlanini Hospital” in Rome
1984 – 1991 – Collaboration with 1° University “La Sapienza” Rome and USL RM/10 3rd Pneumological Division of Carlo Forlanini Hospital - Assistant in Pulmonary and Special Assistant - MD for teaching and research
April 1st to April 30th 1982 - SAKK Ticinese - Oncology Division San Giovanni Bellinzona Hospital - Theoretical and pratical trainee
April 17th 1980 to 1991 - Winner of public announcement - Employee with deliberation on 04/17/80 and from 09/01/1980 employeer in full time - Monteverde Hosp-Sanitary Section - Pneumology Assistant/MD for sanitary-organizing activities in assistance, teaching & and research
Daily clinical activity in multidisciplinary team
Participation in working national and international groups (advisory board, investigator meeting. Etc.)
In the past Scientific Consultant of many Pharmaceutical Companies: Eli Lilly, Astrazeneca,
Sanofi-Aventis. At the present for Roche, and Boehringer Ingelheim
In the last 5 years (2008-12):
Invited Speaker in more than 300 scientific meetings (80% as Speaker and 20% as Chair), whose in 20% of cases took part in Scientific Committee (60 meetings/year). Participation in 40 Advisory Boards and in 17 Investigator Meetings as Speaker.
About scientific international activities in the last 5 years (2008-12)
invited Speaker in 50 International Meetings (10% as chair).
Expert in Good Clinical Practice Trials on New Antineoplastic Drugs in Lung Cancer (phase I, II, III) and developer trials in Lung Cancer with Vinorelbine, Paclitaxel, Docetaxel, Gemcitabine, Topotecan, Pemetrexed, Affinitak, MMPI, SR 48692, Gefitinib, Erlotinib, Cetuximab, BMS 275183, Bevacizumab, Sorafenib, Sunitinib, ASA, 404, Zoledronic Acid, Bortezomib, Vandetanib, Vargatef, Amrubicin, Vorinostat, Panobinostat, CPT-751, Talactoferrin, Eribulin Mesylate, MAGE-3, Stimuvax, Afatinib, Onartuzumab, Ramucirumab, Crizotinib, Dacomitinib, Tivantinib, etc.
In the last 5 years (2008-12) participation in more than 80 clinical studies controlled in phase I-II-III as Principal Investigators (20 new studies/year) recruiting about 80 patients/year (20% Annual casistic)
Author of more than 250 printed scientific publications (14 books/monographers and 125 papers in International Indexed Reviews on PUB MED)
From 1989: 5th European Conference on Clinical Oncology ? ESMO, London-Oncology/European Oncologist From April 1989 - Carlo Forlanini Hospital, Rome IT - Pneumologist Director From November 1983 to July 1986 - 2nd University of Rome ?Cattolica del Sacro Cuore? ? Specialization High School in OncologyExperimental thesis on ?Clinical aspects of bone metastasis from primitive lung carcinoma? - edited for printing paper From November 1978 to July 1971 - 1st University of Rome ?La Sapienza? Experimental thesis on ?Polichemotherapy in the treatment of primitive lung carcinoma at III stage not surgical operable: analysis of secondary toxicity immediate and delayed referring the response and survival April 14th 1978 - 1st University of Rome ?La Sapienza? The Medical and Surgery Faculty Pthsiology: Experimental graduation thesis on ?Chronic bronchitis and allergies?
Director of Thoracic Oncology Division at the European Institute of Oncology (IEO), Milan Italy
Member of scientific Italian and international associations with active roles: AIOT, Italian Thoracic Oncology (president 2007/2012 – past president from 2012)
ESMO (faculty member for chest tumors 2010/2014), ETOP, European Oncological research (member of working group activities in the web) - ASCO, IASLC (member)